22 reports

  • Understanding of stem cell therapy
  • Evolution of new destinations in the development of stem cell therapies

About stem cell therapy Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells,...

  • Stem Cell Therapy
  • JCR Pharmaceuticals Co., Ltd.
  • Mesoblast Limited
  • Osiris Therapeutics, Inc.
  • Vericel Corporation
  • THE STEM CELL THERAPY MARKET
  • THE STEM CELL THERAPY MARKET

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape" provides an in-depth assessment of the current trends in the global stem cell therapy sector with a particular...

  • Stem Cell Therapy
  • Cynata Therapeutics Limited
  • Mesoblast Limited
  • NuVasive, Inc.
  • Orthofix International N.V.
  • GLOBAL STEM CELL THERAPY PIPELINE FOR MULTIPLE SCLEROSIS
  • STEM CELL THERAPY FOR MULTIPLE SCLEROSIS: AN OVERVIEW OF PIPELINE MOLECULES

This pipeline analysis report offers detailed insights into the clinical trials landscape of the stem cell therapy for multiple sclerosis including molecules at different development stages. Moreover, the report also offers information about the therapeutic assessment of the pipeline molecules based on various segmentations including route...

  • Stem Cell Therapy
  • Asterias Biotherapeutics, Inc.
  • Athersys, Inc.
  • Celgene Corporation
  • Enlivex

By therapy the market is segmented by autologous stem cell therapy and allogeneic stem cell therapy.

  • Stem Cell Therapy
  • APAC
  • World
  • Forecast
  • Market Size
  • REGULATORY OVERSIGHT OF STEM CELL THERAPIES
  • STROKE PIPELINE PROFILED STEM CELL THERAPIES

Stem Cell Therapies in CVMD Summary Regenerative medicine could potentially cure diseases and may replace palliative treatments for chronic diseases.Stem cells in particular have been studied for their regenerative properties: their potential to repair or replace damaged or diseased human cells or...

  • Cardiovascular Disease
  • Stem Cell
  • Stem Cell Therapy
  • United States
  • Market Size

List of Tables ## Global Stem Cell Therapy Market Outlook, By Region (2013-2022) ($MN) ## Global Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN) ## Global Stem Cell Therapy Market Outlook

  • Stem Cell Therapy
  • APAC
  • World
  • Forecast
  • Market Size

List of Tables Table ## Global Stem Cell Therapy Market By Region, Market Forecast (2013-2025) (US $MN) Table ## Global Stem Cell Therapy Market By Treatment type, Market Forecast (2013-2025) (US $MN) Table ## Global Stem

  • Biological Therapy
  • Stem Cell Therapy
  • United States
  • Forecast
  • Market Size

Global Stem Cell Therapy Market Future Outlook ##.

  • Biological Therapy
  • Stem Cell
  • Stem Cell Therapy
  • Therapy
  • World

Stem Cell Therapy Global Market Forecast (2014-2020) ## Introduction ##. ## Scope of the Report ##. ## Report Description ##. ## Research Methodology ##. ## Research Sources ##. ##. ## Secondary Research ##. ##. ## Primary Research ##. ##. ## Assumptions ##. ## List of Abbreviations ## Executiv

  • Stem Cell Therapy
  • APAC
  • North America
  • World
  • Market Size
  • STATUS OF STEM CELL THERAPY PIPELINE MOLECULES FOR DIABETES AND RELATED CONDITIONS
  • SEGMENTATION OF STEM CELL THERAPY PIPELINE MOLECULES BASED ON ROA

Stem cell therapy for diabetes and related conditions: An insight The stem cell therapy for diabetes and related conditions pipeline analysis report includes ongoing clinical and non-clinical trends in the global stem cell therapy for diabetes and related conditions treatment. Most of the pipeline therapeutics are in early stage...

  • Stem Cell Therapy
  • United States
  • Orgenesis Inc.
  • Sanofi S.A.
  • ViaCyte, Inc.
  • ALLOGENEIC STEM CELL THERAPY DOMINATES THE STEM CELL THERAPY MARKET IN 2016
  • STEM CELL THERAPY MARKET, BY REGION

The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell...

  • Biological Therapy
  • Cell Therapy
  • Stem Cell Therapy
  • United States
  • MediPost Co., Ltd.
  • STEM CELL THERAPY PIPELINE
  • STEM CELL THERAPY

“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various development phases (Discovery to Phase 2 clinical). The pipeline focuses on disease modification and includes pharmacologic drugs, gene therapy,...

  • Stem Cell Therapy
  • Bioheart, Inc.
  • Celladon Corporation
  • GlaxoSmithKline plc
  • Juventas Therapeutics, Inc.
  • STEM CELL THERAPY FOR X-LINKED SCID - DRUG PROFILE
  • STEM CELL THERAPY FOR HEMATOLOGICAL DISORDERS AND PRIMARY IMMUNE DEFICIENCY - DRUG PROFILE

Primary Immune Deficiency (PID) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H1 2018, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline...

  • Genetic Disorder
  • Infectious Disease
  • Stem Cell Therapy
  • Therapy
  • ADMA Biologics, Inc.
  • Stem Cell Therapy to Activate FANCA Protein for Fanconi Anemia - Drug Profile
  • Stem Cell Therapy to Activate FANCA Protein for Fanconi Anemia - Drug Profile

Fanconi Anemia - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2017, provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline landscape. Fanconi anemia (fan-KO-nee...

  • Blood Disease
  • Stem Cell Therapy
  • Therapy
  • United States
  • Product Initiative
  • STEM CELL THERAPY FOR LEUKOCYTE ADHESION DEFICIENCY - DRUG PROFILE
  • STEM CELL THERAPY FOR X-LINKED SCID - DRUG PROFILE

Primary Immune Deficiency (PID) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H2 2017, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline landscape. Primary...

  • Genetic Disorder
  • Infectious Disease
  • Stem Cell Therapy
  • United States
  • Product Initiative
  • Stem Cell Therapy for Fanconi Anemia - Drug Profile
  • Stem Cell Therapy to Activate FANC-A for Fanconi Anemia - Drug Profile

Fanconi Anemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H1 2018, provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline landscape. Fanconi anemia (fan-KO-nee...

  • Blood Disease
  • Stem Cell Therapy
  • United States
  • World
  • Product Initiative
  • STEM CELL THERAPY FOR MYOCARDIAL INFARCTION - DRUG PROFILE
  • STEM CELL THERAPY FOR MYOCARDIAL INFARCTION - DRUG PROFILE

Myocardial Infarction - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H2 2018, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction...

  • Heart Attack
  • Stem Cell Therapy
  • United States
  • Company
  • Product Initiative
  • STEM CELL THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS - DRUG PROFILE
  • STEM CELL THERAPY FOR ISCHEMIC STROKE - DRUG PROFILE

Stroke - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H1 2018, provides an overview of the Stroke (Cardiovascular) pipeline landscape. Stroke is a condition in which the brain cells suddenly die...

  • Neurological Disorder
  • Stem Cell Therapy
  • United States
  • Company
  • Product Initiative
  • STEM CELL THERAPY FOR HEARING DISORDERS
  • STEM CELL THERAPY FOR LYSOSOMAL STORAGE DISORDER

Fate Therapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Fate Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Fate Therapeutics, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics...

  • Stem Cell Therapy
  • Therapy
  • United States
  • Company Operations
  • Fate Therapeutics, Inc.
  • STEM CELL THERAPY FOR ACUTE LUNG INJURY - DRUG PROFILE
  • STEM CELL THERAPY FOR ACUTE LUNG INJURY - DRUG PROFILE

Acute Lung Injury - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H1 2016’, provides an overview of the Acute Lung Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Lung Injury, complete with...

  • Chronic Disease
  • Respiratory Disease
  • Stem Cell Therapy
  • United States
  • Product Initiative
  • 5.6 EUROPE STEM CELL THERAPY MARKET, BY COUNTRY
  • EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN)

The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America. Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region....

  • Orthobiologics
  • Stem Cell Therapy
  • Europe
  • Market Size
  • Wright Medical Technology, Inc.
  • 5.6 ASIA: STEM CELL THERAPY MARKET, BY COUNTRY
  • ASIA: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN)

The Asian orthobiologics market is expected to present significant growth opportunities for its stakeholders. This market was valued at $1,181.9 million in 2014 and is estimated to reach $1,651.6 million by 2019, at a CAGR of 6.9% from 2014 to 2019. Browse through the TOC of the Asian orthobiologics market, to get an idea of the market...

  • Medical Device
  • Stem Cell Therapy
  • Asia
  • World
  • Market Size